Abstract
Simvastatin (SV) has been reported to improve cognitive deficits in Alzheimer’s disease. Here, we show that chronic administration of SV (20 mg/kg) for 30 days in adult mice (SV mice) enhanced spatial cognitive performance as assessed by Morris water maze and Y-maze. To explore mechanisms underlying SV-enhanced spatial cognition, we further examined synaptic properties and long-term potentiation (LTP) in hippocampal CA1, hippocampal α7nAChR expression, and Akt and ERK2 phosphorylation. In comparison with controls, the SV administration caused increase in presynaptic glutamate release and amplitude of NMDAr-dependent LTP (LTP-augmentation), and decrease in threshold of NMDAr-independent LTP induction (LTP-facilitation). The supplement of isoprenoid farnesyl pyrophosphate (FPP) by applying farnesol (FOH) could abolish the spatial cognitive potentiation, increased glutamate release, and LTP-augmentation/facilitation in SV mice. Expression of α7nAChR, but not α4β2nAChR, was increased in hippocampal pyramidal cells of SV mice with the reduction of transcription factor AP-2α, which were abolished by FOH. Levels of Akt and ERK2 phosphorylation in SV mice were elevated, which were suppressed by FOH or α7nAChR antagonist methyl-lycaconitine (MLA). In hippocampal slices obtained from SV mice, acute perfusion of MLA blocked the increased glutamate release, whereas FOH, PI3K inhibitor LY294002, or MEK inhibitor U0126 could not. In the slices of SV mice, the perfusion of MLA or U0126, but not FOH, abolished the LTP-augmentation and LTP-facilitation. By contrast, LY294002 prevented the LTP-facilitation but failed to affect the LTP-augmentation. The findings indicate that the administration of SV through reducing FPP increases α7nAChR expression and α7nAChR-related Akt and ERK2 phosphorylation, leading to LTP enhancement and spatial cognitive potentiation.
Similar content being viewed by others
References
Fonseca AC, Resende R, Oliveira CR, Pereira CM (2010) Cholesterol and statins in Alzheimer's disease: current controversies. Exp Neurol 223(2):282–293. doi:10.1016/j.expneurol.2009.09.013
Williams PT (2015) Lower risk of Alzheimer's disease mortality with exercise, statin, and fruit intake. J Alzheimers Dis 44(4):1121–1129. doi:10.3233/JAD-141929
Chou CY, Chou YC, Chou YJ, Yang YF, Huang N (2014) Statin use and incident dementia: a nationwide cohort study of Taiwan. Int J Cardiol 173(2):305–310. doi:10.1016/j.ijcard.2014.03.018
Simons M, Schwarzler F, Lutjohann D, von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T et al (2002) Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 52(3):346–350. doi:10.1002/ana.10292
Tong XK, Lecrux C, Rosa-Neto P, Hamel E (2012) Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits. J Neurosci 32(14):4705–4715. doi:10.1523/JNEUROSCI.0169-12.2012
Li L, Cao D, Kim H, Lester R, Fukuchi K (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol 60(6):729–739. doi:10.1002/ana.21053
Roensch J, Crisby M, Nordberg A, Xiao Y, Zhang LJ, Guan ZZ (2007) Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochem Int 50(6):800–806. doi:10.1016/j.neuint.2007.02.001
Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361(6407):31–39. doi:10.1038/361031a0
Chen L, Yamada K, Nabeshima T, Sokabe M (2006) alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. Neuropharmacology 50(2):254–268. doi:10.1016/j.neuropharm.2005.09.018
Leiser SC, Bowlby MR, Comery TA, Dunlop J (2009) A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther 122(3):302–311. doi:10.1016/j.pharmthera.2009.03.009
Zhi WH, Zeng YY, Lu ZH, Qu WJ, Chen WX, Chen L, Chen L (2014) Simvastatin exerts antiamnesic effect in Abeta25-35 -injected mice. CNS Neurosci Ther 20(3):218–226. doi:10.1111/cns.12190
Skaletz-Rorowski A, Lutchman M, Kureishi Y, Lefer DJ, Faust JR, Walsh K (2003) HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc Res 57(1):253–264
Nakao T, Shiota M, Tatemoto Y, Izumi Y, Iwao H (2007) Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling. J Pharmacol Sci 105(4):334–341
Mans RA, Chowdhury N, Cao D, McMahon LL, Li L (2010) Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice. Neuroscience 166(2):435–444. doi:10.1016/j.neuroscience.2009.12.062
Veyrac A, Besnard A, Caboche J, Davis S, Laroche S (2014) The transcription factor Zif268/Egr1, brain plasticity, and memory. Prog Mol Biol Transl Sci 122:89–129. doi:10.1016/B978-0-12-420170-5.00004-0
Endo A (2004) The discovery and development of HMG-CoA reductase inhibitors. 1992. Atheroscler Suppl 5(3):67–80. doi:10.1016/j.atherosclerosissup.2004.08.026
McTaggart SJ (2006) Isoprenylated proteins. Cell Mol Life Sci 63(3):255–267. doi:10.1007/s00018-005-5298-6
Eckert GP, Hooff GP, Strandjord DM, Igbavboa U, Volmer DA, Muller WE, Wood WG (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis 35(2):251–257. doi:10.1016/j.nbd.2009.05.005
Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, Cannon TD, Silva AJ (2005) The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 15(21):1961–1967. doi:10.1016/j.cub.2005.09.043
Xiu J, Nordberg A, Shan KR, Yu WF, Olsson JM, Nordman T, Mousavi M, Guan ZZ (2005) Lovastatin stimulates up-regulation of alpha7 nicotinic receptors in cultured neurons without cholesterol dependency, a mechanism involving production of the alpha-form of secreted amyloid precursor protein. J Neurosci Res 82(4):531–541. doi:10.1002/jnr.20658
Wang C, Chen T, Li G, Zhou L, Sha S, Chen L (2015) Simvastatin prevents beta-amyloid-impaired neurogenesis in hippocampal dentate gyrus through alpha7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate. Neuropharmacology 97:122–132. doi:10.1016/j.neuropharm.2015.05.020
Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T (2010) The Statin Choice decision aid in primary care: a randomized trial. Patient Educ Couns 80(1):138–140. doi:10.1016/j.pec.2009.10.008
Qamar W, Sultana S (2008) Farnesol ameliorates massive inflammation, oxidative stress and lung injury induced by intratracheal instillation of cigarette smoke extract in rats: an initial step in lung chemoprevention. Chem Biol Interact 176(2-3):79–87. doi:10.1016/j.cbi.2008.08.011
Yang R, Chen L, Wang H, Xu B, Tomimoto H, Chen L (2012) Anti-amnesic effect of neurosteroid PREGS in Abeta25-35-injected mice through sigma1 receptor- and alpha7nAChR-mediated neuroprotection. Neuropharmacology 63(6):1042–1050. doi:10.1016/j.neuropharm.2012.07.035
Yin J, Sha S, Chen T, Wang C, Hong J, Jie P, Zhou R, Li L et al (2015) Sigma-1 (sigma(1)) receptor deficiency reduces beta-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B. Neuropharmacology 89:215–224. doi:10.1016/j.neuropharm.2014.09.027
Sha S, Xu J, Lu ZH, Hong J, Qu WJ, Zhou JW, Chen L (2014) Lack of JWA Enhances Neurogenesis and Long-Term Potentiation in Hippocampal Dentate Gyrus Leading to Spatial Cognitive Potentiation. Mol Neurobiol. doi:10.1007/s12035-014-9010-4
Albers KM, Zhang XL, Diges CM, Schwartz ES, Yang CI, Davis BM, Gold MS (2014) Artemin growth factor increases nicotinic cholinergic receptor subunit expression and activity in nociceptive sensory neurons. Mol Pain 10:31. doi:10.1186/1744-8069-10-31
Ghedini PC, Avellar MC, De Lima TC, Lima-Landman MT, Lapa AJ, Souccar C (2012) Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice. Brain Res 1483:96–104. doi:10.1016/j.brainres.2012.09.021
Coelho DJ, Sims DJ, Ruegg PJ, Minn I, Muench AR, Mitchell PJ (2005) Cell type-specific and sexually dimorphic expression of transcription factor AP-2 in the adult mouse brain. Neuroscience 134(3):907–919. doi:10.1016/j.neuroscience.2005.04.060
Maurice T, Lockhart BP, Privat A (1996) Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706(2):181–193
Aggleton JP, Hunt PR, Rawlins JN (1986) The effects of hippocampal lesions upon spatial and non-spatial tests of working memory. Behav Brain Res 19(2):133–146
Mans RA, McMahon LL, Li L (2012) Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation. Neuroscience 202:1–9. doi:10.1016/j.neuroscience.2011.12.007
Finlay-Schultz J, Canastar A, Short M, El Gazzar M, Coughlan C, Leonard S (2011) Transcriptional repression of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2alpha (AP-2alpha). J Biol Chem 286(49):42123–42132. doi:10.1074/jbc.M111.276014
Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A (2001) alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276(17):13541–13546. doi:10.1074/jbc.M008035200
Blake MG, Boccia MM, Krawczyk MC, Baratti CM (2013) Hippocampal alpha7-nicotinic cholinergic receptors modulate memory reconsolidation: a potential strategy for recovery from amnesia. Neurobiol Learn Mem 106:193–203. doi:10.1016/j.nlm.2013.09.001
Kannan P, Buettner R, Chiao PJ, Yim SO, Sarkiss M, Tainsky MA (1994) N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev 8(11):1258–1269
Gu Z, Lamb PW, Yakel JL (2012) Cholinergic coordination of presynaptic and postsynaptic activity induces timing-dependent hippocampal synaptic plasticity. J Neurosci 32(36):12337–12348. doi:10.1523/JNEUROSCI.2129-12.2012
Kawamata J, Shimohama S (2011) Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 24(Suppl 2):95–109. doi:10.3233/JAD-2011-110173
Mozayan M, Chen MF, Si M, Chen PY, Premkumar LS, Lee TJ (2006) Cholinesterase inhibitor blockade and its prevention by statins of sympathetic alpha7-nAChR-mediated cerebral nitrergic neurogenic vasodilation. J Cereb Blood Flow Metab 26(12):1562–1576. doi:10.1038/sj.jcbfm.9600310
Si ML, Long C, Yang DI, Chen MF, Lee TJ (2005) Statins prevent beta-amyloid inhibition of sympathetic alpha7-nAChR-mediated nitrergic neurogenic dilation in porcine basilar arteries. J Cereb Blood Flow Metab 25(12):1573–1585. doi:10.1038/sj.jcbfm.9600232
Maelicke A, Schrattenholz A, Samochocki M, Radina M, Albuquerque EX (2000) Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behav Brain Res 113(1-2):199–206
Colon-Saez JO, Yakel JL (2011) The alpha7 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane. J Physiol 589(Pt 13):3163–3174. doi:10.1113/jphysiol.2011.209494
Abraham WC, Tate WP (1997) Metaplasticity: a new vista across the field of synaptic plasticity. Prog Neurobiol 52(4):303–323
Cheng Q, Yakel JL (2014) Presynaptic alpha7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation. J Neurosci 34(1):124–133. doi:10.1523/JNEUROSCI.2973-13.2014
Hunter BE, de Fiebre CM, Papke RL, Kem WR, Meyer EM (1994) A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci Lett 168(1-2):130–134
Opazo P, Watabe AM, Grant SG, O'Dell TJ (2003) Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J Neurosci 23(9):3679–3688
Thomas GM, Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5(3):173–183. doi:10.1038/nrn1346
Qin Y, Zhu Y, Baumgart JP, Stornetta RL, Seidenman K, Mack V, van Aelst L, Zhu JJ (2005) State-dependent Ras signaling and AMPA receptor trafficking. Genes Dev 19(17):2000–2015. doi:10.1101/gad.342205
Chen L, Miyamoto Y, Furuya K, Mori N, Sokabe M (2007) PREGS induces LTP in the hippocampal dentate gyrus of adult rats via the tyrosine phosphorylation of NR2B coupled to ERK/CREB [corrected] signaling. J Neurophysiol 98(3):1538–1548. doi:10.1152/jn.01151.2006
Wang Q, Zengin A, Deng C, Li Y, Newell KA, Yang GY, Lu Y, Wilder-Smith EP et al (2009) High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain. Exp Neurol 216(1):132–138. doi:10.1016/j.expneurol.2008.11.016
Thornton C, Yaka R, Dinh S, Ron D (2003) H-Ras modulates N-methyl-D-aspartate receptor function via inhibition of Src tyrosine kinase activity. J Biol Chem 278(26):23823–23829. doi:10.1074/jbc.M302389200
Manabe T, Aiba A, Yamada A, Ichise T, Sakagami H, Kondo H, Katsuki M (2000) Regulation of long-term potentiation by H-Ras through NMDA receptor phosphorylation. J Neurosci 20(7):2504–2511
Meyer EM, Tay ET, Papke RL, Meyers C, Huang GL, de Fiebre CM (1997) 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res 768(1-2):49–56
Levin ED, Bettegowda C, Blosser J, Gordon J (1999) AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10(6-7):675–680
Kihara T, Sawada H, Nakamizo T, Kanki R, Yamashita H, Maelicke A, Shimohama S (2004) Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity. Biochem Biophys Res Commun 325(3):976–982. doi:10.1016/j.bbrc.2004.10.132
Ren K, Thinschmidt J, Liu J, Ai L, Papke RL, King MA, Hughes JA, Meyer EM (2007) alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation. Neuroscience 145(1):314–322. doi:10.1016/j.neuroscience.2006.11.023
Acknowledgments
This work was supported by grants for National 973 Basic Research Program of China (2014CB943303) and National Natural Science Foundation of China (81071027; 31171440; 81361120247; 31271206) to Chen L.
Conflict of interest
The authors declare that they have no conflict of interest.
Compliance with Ethical Standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Headings
(1) Chronic administration of simvastatin (SV) enhances spatial memory in mice.
(2) SV enhances hippocampal Schaffer collateral-CA1 synaptic glutamate release and LTP induction in α7nAChR-dependent manner.
(3) SV through reducing farnesyl pyrophosphate increases α7nAChR expression and activity to cascade PI3K-Akt and ERK signaling pathways.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 193 kb)
Rights and permissions
About this article
Cite this article
Chen, T., Wang, C., Sha, S. et al. Simvastatin Enhances Spatial Memory and Long-Term Potentiation in Hippocampal CA1 via Upregulation of α7 Nicotinic Acetylcholine Receptor. Mol Neurobiol 53, 4060–4072 (2016). https://doi.org/10.1007/s12035-015-9344-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9344-6